The government is under renewed pressure to decide on compensation for individuals who have suffered avoidable harm from pelvic mesh and the epilepsy drug sodium valproate.
More than two years after the Hughes Report called for a two-stage redress scheme, its author, Professor Henrietta Hughes, England’s patient safety commissioner, has expressed disappointment over the "continued absence of visible and timely progress".
